ESR1 and breast carcinoma: This conclusion is based on several lines of evidence that DDB2 is highly expressed in the human ER-positive breast tumor samples and in the cell lines we examined, compared to ER-negative status, and plays a significant role as an activator of growth, favouring G1/S transition entry of ER-positive breast cancer cells during their cell cycle.